52 Week HighNatco Pharma has hit a 52wk high of Rs 972.00 on NSE
52 Week HighNatco Pharma has hit a 52wk high of Rs 907.95 on BSE
52 Week HighNatco Pharma has hit a 52wk high of Rs 950.00 on NSE
50% of moneycontrol users recommend buying Natco Pharma.
What's your call on Natco Pharma today?
Read 2 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2720.80||0.06||2939.80||2140.35||46,344.76|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
AIA Engineering Recommended on May 7th 2014
Recommended price 642.00 | Peak from reco 858.00 33.64%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Natco Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 3,789.60 crore.The company has reported a consolidated sales of Rs 186.18 crore and a Net Profit of Rs 27.45 crore for the quarter ended Dec 2013.
The company management includes V C Nannapaneni - Chairman & Managing Director, Rajeev Nannapaneni - Vice Chairman & CEO, T V Rao - Nominee Director, G S Murthy - Director, B S Bajaj - Director, P Bhaskara Narayana - Director & CFO, A K S Bhujanga Rao - President & Director, Vivek Chhacchi - Additional Director, D G Prasad - Additional Director.
It is listed on the BSE with a BSE Code of 524816 and the NSE with an NSE Code of NATCOPHARM.
Its Registered office is at NATCO House, Road No.2,,Banjara Hills Hyderabad,Andhra Pradesh - 500034.
Their Registrars are Venture Capital & Corporate Investments Pvt. Ltd.